Sweden's Indutrade Q2 sales and EBITA beat estimates, helped by acquisitions
Sweden's Indutrade Q2 sales and EBITA beat estimates, helped by acquisitions
Overview
Sweden technology and industrial group's Q2 net sales rose 11%, beating analyst expectations
Q2 EBITA increased 19%, beating analyst expectations, margin improved to 14.7%
Company reported record order intake and continued strong pace of acquisitions
Outlook
Company expects strong order backlog and recent acquisitions to support positive development in H2 2026
Company says significant economic uncertainty remains due to geopolitical situation
Indutrade says it is well positioned in structurally growing market areas entering H2 2026
Result Drivers
ORGANIC GROWTH - Co said organic growth in order intake and net sales contributed to improved results, with positive development in most customer segments and business areas
ACQUISITIONS - Acquisitions contributed to growth in net sales and EBITA, with effects amounting to 6% and 8% respectively in the qtr
MARGIN IMPROVEMENT - EBITA margin improved due to organic sales growth, strong gross margin and positive effects from acquisitions
Company press release: ID:nMFNcfTlyg
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2Net Sales | Beat | SEK 8.99 bln | SEK 8.62 bln (6 Analysts) |
Q2 EPS |
| SEK 2.15 |
|
Q2 Net Income |
| SEK 784 mln |
|
Q2 EBITA | Beat | SEK 1.32 bln | SEK 1.21 bln (5 Analysts) |
Q2 EBITA Margin |
| 14.70% |
|
Q2 Orders |
| SEK 9.41 bln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the industrial machinery & equipment peer group is "buy"
Wall Street's median 12-month price target for Indutrade AB is SEK240.00, about 10.2% above its July 15 closing price of SEK217.80
The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 24 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Indutrade AB
See all newsBrief: Indutrade Acquires Polish Life Science Company Sinmed
Brief: Indutrade Acquires Diagnostic Imaging Specialist Euromed In Poland
Brief: Indutrade Acquires Controlin
Indutrade tops STOXX 600 after Q2 beat, record order intake
Sweden's Indutrade Q2 sales and EBITA beat estimates, helped by acquisitions